肺癌切除术短期结局与长期生存的关联
该研究基于美国国家癌症数据库2010至2019年间928个中心、198115例非小细胞肺癌切除术患者,按术后主要并发症率将中心分为五个等级,最高五分位定义为高质量中心。结果显示高质量中心30天死亡率(0.8% vs 2.4%)和并发症率(中位数5% vs 10.8%)更低,且患者长期生存更优(5年生存率71.5% vs 62.6%;HR 0.75)。
要点
- 高质量中心(短期结局优)肺癌切除患者长期生存更好
- 高质量中心30天死亡率0.8%,非高质量中心2.4%
- 5年生存率高质量中心71.5%,非高质量中心62.6%
核心结论
- 以短期结局定义的高质量中心,其肺癌切除术患者长期生存也更好。
研究设计与样本
- 回顾性队列研究,纳入美国国家癌症数据库2010至2019年间928个中心、198115例非小细胞肺癌切除术患者。
临床怎么用
- 可将短期结局指标作为评估肺癌手术质量的参考,并预期其与长期生存相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Quality metrics that compare care across institutions typically are based on short-term outcomes. This study evaluated whether short-term quality metrics for non-small cell lung cancer (NSCLC) resection predict long-term survival. METHODS: Centers in the National Cancer Database that performed ≥30 NSCLC resections between 2010 and 2019 were ranked based on major postoperative morbidity, defined as a weighted composite of 30-day mortality, unplanned readmissions, and hospital length of stay longer than 14 days. Centers were stratified by morbidity rates into quintiles, with the top quintile designated high quality. The impact of care at high-quality institutions on survival was assessed with Kaplan-Meier analysis and Cox proportional hazards modeling. RESULTS: The study included 198,115 patients from 928 centers. Compared to non-high-quality centers, high-quality centers had lower rates of 30-day mortality (0.8% [n = 362/47,321] vs 2.4% [n = 3614/150,794]: P < .001) and morbidity (median, 5% [interquartile range (IQR), 4.0%-5.9%] vs 10.8% [IQR, 8.7%-14.0%]; P < .001). Patients treated at high-quality centers had improved long-term survival compared to other patients in both univariable analysis (5-year survival, 71.5% [95% confidence interval (CI), 71.0%-71.9%] vs 62.6% [95% CI, 62.3%-62.8%]; P < .0001) and multivariable analysis (hazard ratio [HR], 0.75; 95% CI, 0.73-0.77; P < .001). Sensitivity analysis of stage IA patients treated with lobectomy and no induction therapy showed similar survival benefits as care at high-quality centers in both univariable analysis (5-year survival, 79% [95% CI, 78.3%-79.7%] vs 73.2% [95% CI, 72.8%-73.6%]; P < .001) and multivariable analysis (HR, 0.76; 95% CI, 0.73-0.78; P < .001). CONCLUSIONS: Patients who underwent lung cancer resection at institutions deemed high-quality based on short-term outcomes also had better long-term survival.
引用
- Woodson DRP, Kapula N, Liou DZ, et al. Association of short-term outcomes and long-term survival after lung cancer resection. J Thorac Cardiovasc Surg. 2025. PMID: 41260411. doi:10.1016/j.jtcvs.2025.11.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。